NASDAQ: STAA
Staar Surgical Co Stock

$17.38-0.43 (-2.41%)
Updated Jul 11, 2025
STAA Price
$17.38
Fair Value Price
$24.39
Market Cap
$860.76M
52 Week Low
$13.50
52 Week High
$46.79
P/E
-11.99x
P/B
2.46x
P/S
3.15x
PEG
N/A
Dividend Yield
N/A
Revenue
$279.13M
Earnings
-$71.08M
Gross Margin
74%
Operating Margin
-21.97%
Profit Margin
-25.5%
Debt to Equity
0.31
Operating Cash Flow
-$12M
Beta
1.41
Next Earnings
Aug 6, 2025
Ex-Dividend
N/A
Next Dividend
N/A

STAA Overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine STAA's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical

Industry Rating
C
STAA
Ranked
#39 of 45

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$5.80A
$10.47B
$93.49B
View Top Medical Stocks

Be the first to know about important STAA news, forecast changes, insider trades & much more!

STAA News

Overview

Due Diligence Score

Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how STAA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

STAA ($17.38) is undervalued by 28.73% relative to our estimate of its Fair Value price of $24.39 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
STAA ($17.38) is significantly undervalued by 28.73% relative to our estimate of its Fair Value price of $24.39 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
STAA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more STAA due diligence checks available for Premium users.

Valuation

STAA fair value

Fair Value of STAA stock based on Discounted Cash Flow (DCF)

Price
$17.38
Fair Value
$24.39
Undervalued by
28.73%
STAA ($17.38) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
STAA ($17.38) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
STAA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

STAA price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-11.99x
Industry
38.69x
Market
30.99x

STAA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.46x
Industry
3.63x
STAA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

STAA's financial health

Profit margin

Revenue
$42.6M
Net Income
-$54.2M
Profit Margin
-127.3%
STAA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
STAA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$457.4M
Liabilities
$107.4M
Debt to equity
0.31
STAA's short-term assets ($326.50M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
STAA's short-term assets ($326.50M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
STAA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
STAA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.7M
Investing
$35.4M
Financing
-$948.0k
STAA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

STAA vs Medical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
STAAD$860.76M-2.41%-11.99x2.46x
KMTSD$765.61M-1.84%N/A-2.79x
BLFSC$1.04B-3.39%-60.97x2.96x
PLSED$1.08B-6.37%-16.36x9.10x
EMBCB$611.89M-2.42%11.63x-0.83x

Staar Surgical Co Stock FAQ

What is Staar Surgical Co's quote symbol?

(NASDAQ: STAA) Staar Surgical Co trades on the NASDAQ under the ticker symbol STAA. Staar Surgical Co stock quotes can also be displayed as NASDAQ: STAA.

If you're new to stock investing, here's how to buy Staar Surgical Co stock.

What is the 52 week high and low for Staar Surgical Co (NASDAQ: STAA)?

(NASDAQ: STAA) Staar Surgical Co's 52-week high was $46.79, and its 52-week low was $13.50. It is currently -62.86% from its 52-week high and 28.74% from its 52-week low.

How much is Staar Surgical Co stock worth today?

(NASDAQ: STAA) Staar Surgical Co currently has 49,526,129 outstanding shares. With Staar Surgical Co stock trading at $17.38 per share, the total value of Staar Surgical Co stock (market capitalization) is $860.76M.

Staar Surgical Co stock was originally listed at a price of $17.19 in Dec 31, 1997. If you had invested in Staar Surgical Co stock at $17.19, your return over the last 27 years would have been 1.11%, for an annualized return of 0.04% (not including any dividends or dividend reinvestments).

How much is Staar Surgical Co's stock price per share?

(NASDAQ: STAA) Staar Surgical Co stock price per share is $17.38 today (as of Jul 11, 2025).

What is Staar Surgical Co's Market Cap?

(NASDAQ: STAA) Staar Surgical Co's market cap is $860.76M, as of Jul 13, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Staar Surgical Co's market cap is calculated by multiplying STAA's current stock price of $17.38 by STAA's total outstanding shares of 49,526,129.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.